In patients with hypopharyngeal SCC, expression of p-Akt and p-Erk has been shown to be remarkably elevated parallel with progression of clinical stage, indicating the possible roils of PI3K/Akt and MAPK/ERK pathways in evolution and progression of this type of cancer. The gene discussed is AKT1; the disease is cancer.